FMO5 and chronic kidney disease: Sustained activation of the renin–angiotensin system is associated with the progression of CKD, such as diabetic nephropathy, which accounts for over 30% of end-stage renal diseases, in part by Ang II-induced activation of NADPH oxidase and production of ROS and inflammatory cytokines.